论文部分内容阅读
用在体内、体外有抗溶组织内阿米巴作用的新药甲硝磺酰咪唑治疗了30名急性、慢性肠道阿米巴病患者。10例急性阿米巴痢疾患者给予该药150毫克,1日4次连服10天,其中8例的临床症状和寄生虫学检查获得了治愈。10例慢性肠道阿米巴患者给予该药150毫克,1日4次连服10天,其中6例的寄生虫学检查获得了治愈;另外10例用甲硝乙基磺酰咪唑300毫克,1日4次共服7天,8例的寄生虫学检查获得了治愈。
Thirty patients with acute and chronic intestinal amoebiasis were treated with the new drug mefenamic-imidazole, which is used in vivo and in vitro for the resistance to Entamoeba histolytica. 10 cases of patients with acute amoebic dificiency given the drug 150 mg, 4 times a day for 10 days, of which 8 cases of clinical symptoms and parasitic examination was cured. Ten patients with chronic enteric-coated amoebic patients were given 150 mg of the drug, 4 times a day for 10 days, of which 6 cases of parasitic examination was cured; the other 10 cases with metronidazole ethyl imidazole 300 mg, 4 times a day for a total of 7 days, 8 cases of parasitology was cured.